EUIPO trademark

AMGLIDIA

RegisteredEUIPOWord markClass 5

"AMGLIDIA" is a word mark owned by Bioprojet Pharma, filed at the EUIPO on May 31, 2017. It is registered and covers class 5 (Pharmaceuticals).

View Bioprojet Pharma portfolioGet this data via the API
Official EUIPO record
AMGLIDIA
Word mark as filed with the EUIPO
Status
Registered
Since September 15, 2017
Filed
May 31, 2017
Registered
September 13, 2017
Expires
May 31, 2027
Application no.
016792194
Registration no.
016792194
Office
EUIPO
European Union Intellectual Property Office
Mark type
Word mark
1 class
Ownership

Who owns AMGLIDIA

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Owner

Bioprojet Pharma

10 trademarks in the portfolioView company

Representative

Cabinet Lavoix

Cabinet Lavoix

Goods and services

What the mark covers

The products and services AMGLIDIA is filed for, grouped by Nice class.

History

What has happened so far

Steps recorded by the EUIPO, newest first.

  1. Bulletin 2024/200 Section C.2.1
  2. Bulletin 2024/083 Section C.2.1
  3. Bulletin 2024/039 Section C.1.1
  4. Bulletin 2024/034 Section C.2.2
  5. Bulletin 2024/033 Section C.1.1
  6. Bulletin 2023/144 Section C.2.1
  7. Bulletin 2020/150 Section C.1.1
  8. Bulletin 2017/176 Section B.1
  9. Bulletin 2017/105 Section A.1
FAQ

About AMGLIDIA

Who owns the trademark "AMGLIDIA"?

The EUIPO trademark "AMGLIDIA" (application 016792194) is owned by Bioprojet Pharma.

What is the status of "AMGLIDIA"?

Its status at the EUIPO is: registered.

When was "AMGLIDIA" registered?

It was registered on September 13, 2017 and is due to expire on May 31, 2027.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull AMGLIDIA and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

Get API keyView docs
GET /v1/trademarks/{id}
ID=tm_019d45dc-b2a3-72bf-9bed-afd5888cde78
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_019d45dc-b2a3-72bf-9bed-afd5888cde78",
  "object": "trademark",
  "mark_text": "AMGLIDIA",
  "status": {
    "primary": "active",
    "stage": "registered"
  },
  "office_code": "EM",
  "application_number": "016792194",
  "filing_date": "2017-05-31",
  "nice_classes": [
    5
  ],
  "owners": [
    {
      "name": "BIOPROJET PHARMA",
      "entity_id": "ent_019fdaa4-d634-7799-8e78-b74d5c3bc376"
    }
  ]
}